Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
PRIORITY PRESS - European Respiratory Society (ERS) Annual Congress 2013
Emerging Bronchodilation Strategies for Improved COPD Control and Progression
Barcelona, Spain / September 7-11, 2013
Barcelona - In the treatment algorithm for chronic obstructive pulmonary disease (COPD), the early combination of bronchodilators is expected to be moved forward in guideline-based treatment. In the GOLD (Global Initiative for Chronic...
PRIORITY PRESS - European Respiratory Society (ERS) Annual Congress 2013
COPD Moves Toward Individualization of Care: Based on Need to Maximize Treatment Options
Barcelona, Spain / September 7-11, 2013
Barcelona - Based on a survey presented as a latebreaking presentation at the 2013 ERS, almost all specialists in chronic obstructive pulmonary disease (COPD) are aware of the GOLD (Global Initiative for Chronic Obstructive Lung Disease)...
MEDICAL FRONTIERS - European Respiratory Society (ERS) Annual Congress 2013
New Treatment Options in Pulmonary Arterial Hypertension Appear to Move Treatment Goals Beyond Symptom Control
Barcelona, Spain / September 7-11, 2013
Barcelona - New data presented at the ERS 2013 from trials published just weeks before the meeting was convened, document a paradigm shift in the treatment of pulmonary hypertension. In pulmonary arterial hypertension, the benefit of a new...
PRIORITY PRESS - International Conference of the American Thoracic Society
Updates in the Treatment of Chronic Thromboembolic Pulmonary and Pulmonary Arterial Hypertension
Philadelphia, Pennsylvania / May 17-22, 2013
Philadelphia - Currently, the gold standard for chronic thromboembolic pulmonary hypertension (CTEPH) is pulmonary endarterectomy (PEA) but when patients are deemed inoperable or when symptoms persist or recur following PEA, new medical...
PRIORITY PRESS - AMMI Canada - CACMID Annual Conference
New NACI Guidelines for Pneumococcal Disease Prevention in High-Risk Adults
Québec City, Quebec/ April 4-6, 2013
Québec City - Prevention of pneumococcal and other vaccine-preventable diseases is challenging in patients with immune deficiency. Vaccines are less immunogenic in this population. Many patients have not had recommended...
MEDICAL FRONTIERS - International Conference of the American Thoracic Society
Simplifying the Management of Chronic Obstructive Pulmonary Disease
San Francisco, California / May 18-23, 2012
San Francisco - Bronchodilators are central to the management of symptomatic chronic obstructive pulmonary disease (COPD). Both long-acting beta agonists (LABAs) and anticholinergics (LAACs) have been an important step toward minimizing...
PHYSICIAN PERSPECTIVE - Viewpoint based on the following article: J Allergy Clin Immunol 2010;125(3):600-8.
Current Control and Future Risk of Asthma Exacerbations: Maintenance and Reliever Strategies Revisited
May 2012
Guest Editor: Malcolm Sears, MB, ChB, FRACP, FRCPC, FAAAAI Professor of Medicine Division of Respirology St. Joseph’s HealthcareEndowed Chair in Respiratory Epidemiology McMaster UniversityHamilton, Ontario Introduction In...
PRIORITY PRESS - American Heart Association 2011 Scientific Sessions
Pulmonary Arterial Hypertension: Addressing the Challenge of Early Diagnosis and Treatment
Orlando, Florida / November 12-16, 2011
Orlando - As initial symptoms are non-specific, early diagnosis of pulmonary arterial hypertension (PAH) is challenging. Echocardiography is the best screening tool but a definitive right heart catheterization should not be delayed as early...
PRIORITY PRESS - Family Medicine Forum 2011
Asthma Management: The Goal Is Control
Montréal, Quebec / November 3-5, 2011
Chief Medical Editor: Dr. Léna Coïc, Montréal, Quebec Despite great advances in therapy, asthma produces considerable morbidity and economic and social costs. Although mortality has been substantially reduced, about 80%...